AMCP Format 4.1 includes new sections describing the evidence needs of HCDMs for unapproved products nearing the end of the product development pipeline, as well as unapproved uses of existing products for which FDA approval is being sought.
On April 19, AMCP submitted joint recommendations to CMS on Medicare Advantage enrollees seeking COVID-19 vaccine without their Original Medicare card. CMS is recommended to present clear guidance to all vaccination sites and providers and instruct MACs to provide assistance to providers to ensure vaccine administration is accurately reimbursed and entered into the COVAX portal.
AMCP submitted a letter on the reopened comment period for the Medicaid Coverage of Innovative Technologies rule, which created a pathway for fast national Medicare coverage of innovative technologies, including digital therapeutics.
The Academy of Managed Care Pharmacy (AMCP) and AMCP Foundation recognized a group of leaders who have contributed significantly to the profession of managed care pharmacy in a special session during AMCP 2021. There were ten awards presented during the April 15, 2021 session.
April 2021 News & Views includes: Register for AMCP 2021; AMCP Advocates on Behalf of Members With Letter to ACCME, Spotlighting Women in Health Care; Celebrating the 2021 P&T Competition Finalist Teams.
AMCP has selected Drake Reiter, PharmD, RPh, as its 2021–2022 Executive Fellow in Health Care Association Leadership. This year-long training program provides a rich, in-depth learning experience for pharmacists interested in a career in health care association leadership or managed care pharmacy.
AMCP strongly believes that our PBM members are key to developing credible, evidence-based education at our national meetings and other educational activities, and we will continue to include these members on our Educational Affairs Committee and as valued faculty.
